We are live on ! Find out more
BCM

BluePath Capital Management Portfolio holdings

AUM $182M
1-Year Est. Return 38.9%
This Fund
S&P 500
This Quarter Est. Return
-3.57%
1 Year Est. Return
+38.9%
3 Year Est. Return
+101.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
-$3.26M
Cap. Flow
+$7.4M
Cap. Flow %
5.1%
Top 10 Hldgs %
35.5%
Holding
120
New
21
Increased
53
Reduced
36
Closed
9

Top Buys

Rank Stock Value
1
NBIS
Nebius Group N.V.
NBIS
+$1.33M
2
MRK icon
Merck
MRK
+$1.28M
3
BOXX icon
Alpha Architect 1-3 Month Box ETF
BOXX
+$1.24M
4
AMGN icon
Amgen
AMGN
+$1.17M
5
PAA icon
Plains All American Pipeline
PAA
+$1.16M

Top Sells

Rank Stock Value
1
FIAX icon
Nicholas Fixed Income Alternative ETF
FIAX
+$2.08M
2
CB icon
Chubb
CB
+$1.25M
3
CYBR
CyberArk
CYBR
+$1.18M
4
CELH icon
Celsius Holdings
CELH
+$1.13M
5
XYZ
Block Inc
XYZ
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 18.14%
2 Financials 9.5%
3 Consumer Discretionary 8.26%
4 Healthcare 6.41%
5 Communication Services 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
26
Coca-Cola
KO
$354B
$1.36M 0.94%
17,857
+1,254
+8% +$94.8K
MRK icon
27
Merck
MRK
$324B
$1.33M 0.92%
+11,045
New +$1.28M
BMY icon
28
Bristol-Myers Squibb
BMY
$127B
$1.31M 0.9%
21,549
+256
+1% +$14.9K
ETN icon
29
Eaton
ETN
$157B
$1.29M 0.89%
3,606
+74
+2% +$26.3K
PLOW icon
30
Douglas Dynamics
PLOW
$1.07B
$1.28M 0.89%
30,501
-2,609
-8% -$105K
PLTR icon
31
Palantir
PLTR
$295B
$1.28M 0.89%
8,769
-24
-0.3% -$3.67K
ABBV icon
32
AbbVie
ABBV
$458B
$1.28M 0.88%
5,882
+591
+11% +$131K
MS icon
33
Morgan Stanley
MS
$337B
$1.28M 0.88%
7,758
-858
-10% -$149K
PAA icon
34
Plains All American Pipeline
PAA
$17.4B
$1.27M 0.88%
+56,975
New +$1.16M
ORCL icon
35
Oracle
ORCL
$331B
$1.21M 0.83%
8,217
+1,492
+22% +$243K
ABT icon
36
Abbott
ABT
$180B
$1.21M 0.83%
11,752
+2,260
+24% +$255K
GS icon
37
Goldman Sachs
GS
$313B
$1.2M 0.83%
1,422
-107
-7% -$95.5K
GILD icon
38
Gilead Sciences
GILD
$161B
$1.19M 0.82%
8,546
+2
+0% +$280
BAC icon
39
Bank of America
BAC
$435B
$1.18M 0.81%
24,144
+6
+0% +$310
BTI icon
40
British American Tobacco
BTI
$132B
$1.17M 0.8%
19,930
+755
+4% +$44.7K
AMGN icon
41
Amgen
AMGN
$203B
$1.16M 0.8%
+3,289
New +$1.17M
WES icon
42
Western Midstream Partners
WES
$19.6B
$1.16M 0.8%
28,061
+2,762
+11% +$114K
GSL icon
43
Global Ship Lease
GSL
$1.57B
$1.15M 0.8%
30,973
-4,904
-14% -$185K
DKS icon
44
Dick's Sporting Goods
DKS
$18.4B
$1.15M 0.79%
5,775
-5
-0.1% -$1.01K
APP icon
45
Applovin
APP
$132B
$1.14M 0.79%
2,866
-655
-19% -$317K
O icon
46
Realty Income
O
$61.2B
$1.13M 0.78%
18,396
+1,484
+9% +$92.9K
DLTR icon
47
Dollar Tree
DLTR
$23.1B
$1.12M 0.78%
10,257
-861
-8% -$105K
AFL icon
48
Aflac
AFL
$63.9B
$1.12M 0.78%
10,236
+1,123
+12% +$124K
SPOT icon
49
Spotify
SPOT
$99.2B
$1.12M 0.77%
2,300
+466
+25% +$234K
VST icon
50
Vistra
VST
$55.1B
$1.11M 0.76%
7,360
+647
+10% +$105K
1
2
3 4 5

Similar funds

TCPG
Trivant Custom Portfolio Group San Diego, California $182M AUM 19.54% 1-Year Est. Return
MAM
MWA Asset Management Lexington, Massachusetts $183M AUM 41.7% 1-Year Est. Return
WA
WESPAC Advisors Orinda, California $183M AUM 29.81% 1-Year Est. Return
WCM
Wisconsin Capital Management Madison, Wisconsin $182M AUM 38.99% 1-Year Est. Return
ACG
Ampersand Capital Group Burlingame, California $183M AUM 3.46% 1-Year Est. Return
CF
Claris Financial Glen Allen, Virginia $183M AUM 17.41% 1-Year Est. Return
QC
Quantedge Capital Singapore $183M AUM 37.27% 1-Year Est. Return
RS
R Squared Central, Hong Kong $182M AUM 18.52% 1-Year Est. Return

BluePath Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, BluePath Capital Management held 120 positions worth $145M, down 2.2% from $148M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

BluePath Capital Management deployed $7.4M of net new capital in Q1 2026, opening 21 new positions and adding to 53 existing holdings. Its largest new stake was Merck: 11,045 shares worth $1.33M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Nicholas Fixed Income Alternative ETF, an estimated $2.08M trimmed.

  • BluePath Capital Management's largest Q1 2026 buy was Merck: 11,045 shares worth $1.33M.
  • BluePath Capital Management added most to Nebius Group N.V. in Q1 2026, an estimated $1.33M increase.
  • BluePath Capital Management's biggest Q1 2026 reduction was Nicholas Fixed Income Alternative ETF, cutting an estimated $2.08M.
  • BluePath Capital Management fully exited CyberArk in Q1 2026, selling an estimated $1.18M.
  • BluePath Capital Management's ten largest holdings make up 35% of its $145M portfolio in Q1 2026.
  • BluePath Capital Management opened 21 new positions and closed 9 in Q1 2026.
  • BluePath Capital Management's portfolio value fell 2.2% quarter-over-quarter to $145M.

Based on BluePath Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.